Company intelligence / Profile preview

PSK Pharma

Dubna, Moscow Oblast, Russia

Ownership: Private
Employees: ~600
Development stage: Other

Overview

PSK Pharma is a leading Russian pharmaceutical developer and manufacturer specializing in high-tech products for respiratory diseases, oncology, and orphan conditions. They have successfully commercialized several biosimilars and a wide range of inhalation therapies, becoming a key player in the Russian import substitution program with an integrated R&D and manufacturing facility in Dubna.

Therapeutic areas: ImmunologyDermatologyPulmonologyRare DiseasesOncology
Modalities: Small moleculeMonoclonal antibodyRecombinant proteinBiologic
Industry: Biotech

Partnerships

Ministry of Industry and Trade of the Russian FederationGovernment of the Moscow Region

Beyond the preview

Go deeper on PSK Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PSK Pharma.

Explore the full profile